Products
Biogen Idec's products include multiple sclerosis (MS) treatments Avonex (interferon beta-1a) and Tysabri (natalizumab); the latter is also approved for treatment of Crohn's disease, and is co-marketed with Élan. Biogen Idec also makes Rituxan (rituximab), a treatment for non-Hodgkin's lymphoma which is also approved for rheumatoid arthritis; Rituxan is co-marketed with Genentech. The company acquired Fumaderm (fumaric acid esters), a psoriasis treatment (licensed in Germany) when it acquired Fumapharm AG in 2006. In December, 2007, Biogen Idec sold the U.S. rights for Zevalin (ibritumomab tiuxetan), another treatment for non-Hodgkin's lymphoma, to Cell Therapeutics, but continues to produce it for European marketing partner Bayer Schering Pharma. In 2006, the company sold rights for Amevive (alefacept), another psoriasis treatment, to Astellas Pharma, continuing to manufacture the drug under contract.
The company's experimental drug BG-12 (dimethyl fumarate) is in late stage clinical trials. BG-12 is designed to treat relapsing-remitting MS. When given twice daily, BG-12 cut the relapse rate by 44 percent at two years compared with a placebo. When given three times a day, it cut the relapse rate by 51 percent. If approved BG-12 could become the world's leading treatment for MS.
Read more about this topic: Biogen Idec
Famous quotes containing the word products:
“It seemed there was a sort of poisoning, an auto-infection of the organisms, so Dr. Krokowski said; it was caused by the disintegration of a substance ... and the products of this disintegration operated like an intoxicant upon the nerve-centres of the spinal cord, with an effect similar to that of certain poisons, such as morphia, or cocaine.”
—Thomas Mann (1875–1955)
“The reality is that zero defects in products plus zero pollution plus zero risk on the job is equivalent to maximum growth of government plus zero economic growth plus runaway inflation.”
—Dixie Lee Ray (b. 1924)
“Good wine needs no bush,
And perhaps products that people really want need no
hard-sell or soft-sell TV push.
Why not?
Look at pot.”
—Ogden Nash (1902–1971)